RANKL down-regulates the mast cell proliferation through inducing senescence

Area of Science:

• Immunology
• Cell Biology
• Molecular Biology

Background:

• Mast cells play a crucial role in inflammatory and allergic conditions.
• The receptor activator of NF-κB ligand (RANKL)/RANK system is implicated in mast cell-mediated allergic reactions.
• The precise function of RANKL in mast cell proliferation requires further elucidation.

Purpose of the Study:

• To investigate the role of RANKL in regulating mast cell proliferation.
• To determine the molecular mechanisms by which RANKL affects mast cell growth and survival.

Main Methods:

• Utilized human mast cell line (HMC-1) and rat peritoneal mast cells.
• Assessed mast cell proliferation, viability, and senescence markers.
• Quantified mRNA and protein expression of key regulatory molecules (e.g., MDM2, Ki-67, p53, p21, p16, pRb).
• Investigated the effect of RANKL on thymic stromal lymphopoietin (TSLP)-stimulated mast cells.

Main Results:

• RANKL significantly inhibited HMC-1 cell proliferation in a dose-dependent manner.
• RANKL reduced cell viability and induced cellular senescence by altering p53 pathway components and retinoblastoma protein.
• RANKL suppressed TSLP-induced mast cell proliferation, downregulating MDM2, Ki-67, and interleukin-13, while increasing senescence markers.

Conclusions:

• RANKL inhibits mast cell proliferation primarily by inducing cellular senescence.
• RANKL may represent a novel therapeutic target for managing mast cell-driven inflammatory diseases.
• The findings clarify the previously unknown role of RANKL in mast cell biology.